Choroidal thickness and visual prognosis in type 1 lesion due to neovascular age-related macular degeneration.
CONCLUSIONS: Thicker subfoveal choroid was associated with better visual outcomes in patients with type 1 CNV due to nAMD following a strict PRN regimen with intravitreal ranibizumab at 24 months of follow-up.
PMID: 27646337 [PubMed - as supplied by publisher]
Source: European Journal of Ophthalmology - Category: Opthalmology Authors: Hernández-Martínez P, Dolz-Marco R, Hervás-Marín D, Andreu-Fenoll M, Gallego-Pinazo R, Arévalo JF Tags: Eur J Ophthalmol Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Eyes | Lucentis | Opthalmology | PET Scan | Ranibizumab Injection | Statistics | Study